Inhibition of Small-Conductance Ca ²⁺ -Activated K ⁺ Channels Terminates and Protects Against Atrial Fibrillation

Abstract

Inhibition of SK channels prolongs atrial effective refractory period without affecting QT interval and prevents and terminates AF ex vivo and in vivo, thus offering a promising new therapeutic opportunity in the treatment of AF.